Ratings Organo Corporation

Equities

6368

JP3201600008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-10 am EDT			5-day change	1st Jan Change
8,500 ^JPY	+5.99%		+6.52%	+45.55%

Feb. 09	Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	CI
2023	Organo Corporation Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Over the past four months, analysts' average price target has been revised upwards significantly.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company benefits from high valuations in earnings multiples.
The company appears highly valued given the size of its balance sheet.
The company is highly valued given the cash flows generated by its activity.
The company is not the most generous with respect to shareholders' compensation.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Environmental Services & Equipment

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ORGANO CORPORATION	+45.55%	2.51B		-
DONALDSON COMPANY, INC.	+15.01%	9.05B		B
EUREKA FORBES LIMITED	-11.82%	1.04B	-	D
CECO ENVIRONMENTAL CORP.	+22.83%	870M		B
ION EXCHANGE (INDIA) LIMITED	-7.53%	765M	-	C+
MONTANA TECHNOLOGIES CORPORATION	+20.48%	696M	-	-
NEDERMAN HOLDING AB	+16.71%	679M	-	B
CANATURE HEALTH TECHNOLOGY CO., LTD.	+14.03%	553M	-	-
MAYAIR TECHNOLOGY (CHINA) CO., LTD.	-14.98%	601M	-	-
ZHEJIANG FEIDA ENVIRONMENTAL SCIENCE & TECHNOLOGY CO., LTD.	-4.45%	580M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes